SKI Market

A+| A| A-|

Indian Indices

Sensex

76,664.21 -999.79
( -1.29%)

Global Indices

Nasdaq

49,330.80 -180.24
(-0.36%)

Dow Jones

7,129.46 -29.44
(-0.41%)

Hang Seng

59,744.07 603.84
(1.02%)

Nikkei 225

10,387.94 -69.07
(-0.66%)

Forex

USD-INR

93.75 0.31
(0.34%)

EUR-INR

109.98 0.10
(0.09%)

GBP-INR

126.66 0.42
(0.33%)

JPY-INR

0.59 0.00
(0.23%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524715

INE044A01036

99.2482659

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SUNPHARMA

92.35

403052.28

EPS(TTM)

Face Value()

Div & Yield %

18.19

0.95

Back

Ruby Mills standalone net profit rises 292.50% in the September 2025 quarter

Nov 14,2025

Net profit of Ruby Mills rose 292.50% to Rs 10.99 crore in the quarter ended September 2025 as against Rs 2.80 crore during the previous quarter ended September 2024. Sales rose 66.68% to Rs 85.64 crore in the quarter ended September 2025 as against Rs 51.38 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	85.64	51.38	67
OPM %	18.79	9.60	-
PBDT	17.20	6.34	171
PBT	14.40	3.47	315
NP	10.99	2.80	293

76,664.21 -999.79 ( -1.29%)

49,330.80 -180.24 (-0.36%)

7,129.46 -29.44 (-0.41%)

59,744.07 603.84 (1.02%)

10,387.94 -69.07 (-0.66%)

93.75 0.31 (0.34%)

109.98 0.10 (0.09%)

126.66 0.42 (0.33%)

0.59 0.00 (0.23%)